WO2008012413A3 - Derives de pyrimidinone et leur utilisation comme medicament - Google Patents
Derives de pyrimidinone et leur utilisation comme medicament Download PDFInfo
- Publication number
- WO2008012413A3 WO2008012413A3 PCT/FR2007/001205 FR2007001205W WO2008012413A3 WO 2008012413 A3 WO2008012413 A3 WO 2008012413A3 FR 2007001205 W FR2007001205 W FR 2007001205W WO 2008012413 A3 WO2008012413 A3 WO 2008012413A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- pyrimidinone derivatives
- products
- receptors
- cannabinoid receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009521289A JP2009544668A (ja) | 2006-07-27 | 2007-07-13 | ピリミジノンの誘導体及びそれらの医薬としての利用 |
US12/375,212 US20090325933A1 (en) | 2006-07-27 | 2007-07-13 | Pyrimidinone Derivatives and Their Use as a Drug |
EP07803868A EP2054419A2 (fr) | 2006-07-27 | 2007-07-13 | Derives de pyrimidinone et leur utilisation comme medicament |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606864A FR2904318B1 (fr) | 2006-07-27 | 2006-07-27 | Derives de pyrimidinone et leur utilisation comme medicament |
FR0606864 | 2006-07-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008012413A2 WO2008012413A2 (fr) | 2008-01-31 |
WO2008012413A3 true WO2008012413A3 (fr) | 2008-05-22 |
Family
ID=37774782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2007/001205 WO2008012413A2 (fr) | 2006-07-27 | 2007-07-13 | Derives de pyrimidinone et leur utilisation comme medicament |
Country Status (5)
Country | Link |
---|---|
US (1) | US20090325933A1 (fr) |
EP (1) | EP2054419A2 (fr) |
JP (1) | JP2009544668A (fr) |
FR (1) | FR2904318B1 (fr) |
WO (1) | WO2008012413A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009001214A2 (fr) * | 2007-06-28 | 2008-12-31 | Pfizer Products Inc. | Dérivés de thieno[2,3-d]pyrimidin-4(3h)-one, d'isoxazolo[5,4-d]pyrimidin-4(5h)-one et d'isothiazolo[5,4-d]pyrimidin-4(5h)-one utilisés comme antagonistes du récepteur du calcium |
UA115576C2 (uk) * | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
SG11201804901WA (en) | 2015-12-22 | 2018-07-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
CA3066939A1 (fr) | 2017-06-21 | 2018-12-27 | SHY Therapeutics LLC | Composes interagissant avec la superfamille ras destines a etre utilises dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050038053A1 (en) * | 2003-06-10 | 2005-02-17 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
US20050176742A1 (en) * | 2003-06-10 | 2005-08-11 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
-
2006
- 2006-07-27 FR FR0606864A patent/FR2904318B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-13 US US12/375,212 patent/US20090325933A1/en not_active Abandoned
- 2007-07-13 JP JP2009521289A patent/JP2009544668A/ja not_active Abandoned
- 2007-07-13 EP EP07803868A patent/EP2054419A2/fr not_active Withdrawn
- 2007-07-13 WO PCT/FR2007/001205 patent/WO2008012413A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050038053A1 (en) * | 2003-06-10 | 2005-02-17 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
US20050176742A1 (en) * | 2003-06-10 | 2005-08-11 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
Also Published As
Publication number | Publication date |
---|---|
FR2904318A1 (fr) | 2008-02-01 |
JP2009544668A (ja) | 2009-12-17 |
EP2054419A2 (fr) | 2009-05-06 |
US20090325933A1 (en) | 2009-12-31 |
WO2008012413A2 (fr) | 2008-01-31 |
FR2904318B1 (fr) | 2011-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008076754A3 (fr) | Composés et compositions utilisés comme inhibiteurs de l'activité du récepteur cannabinoïde 1 | |
WO2004075823A8 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
WO2007021937A3 (fr) | Derives heterocycliques insatures | |
WO2008005908A3 (fr) | Dérivés de pyridoïmidazole | |
IL189008A (en) | History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane | |
WO2006047516A3 (fr) | Composes et compositions servant d'inhibiteurs d'activite de recepteur cannabinoide de type 1 | |
WO2010069532A8 (fr) | Anticorps dirigés contre l'angiopoïétine 2 humaine | |
WO2005000820A3 (fr) | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1 | |
WO2008049116A3 (fr) | Indoles substitués | |
GEP20146101B (en) | Pyridine and pyrazine derivatives as protein kinase modulators | |
WO2008021851A3 (fr) | Nouveaux composés comme antagonistes ou agonistes inverses pour les récepteurs d'opioïdes | |
WO2010048332A3 (fr) | Composés de traitement de maladies et troubles ophtalmiques | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
WO2007149865A3 (fr) | Procédés et compositions liés à l'inhibition de la synthèse de la céramide | |
WO2007109279A3 (fr) | Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation | |
WO2004089951A8 (fr) | Derives d’imidazo-pyridine ayant une affinite sur des recepteurs de la melanocortine | |
WO2009071690A3 (fr) | Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine | |
WO2009071689A3 (fr) | Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine | |
HK1105197A1 (en) | Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors | |
WO2007093880A3 (fr) | Nouveaux dérivés d'indolopyrone et leur procédé de préparation | |
WO2008087366A3 (fr) | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation | |
WO2009115084A3 (fr) | Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations | |
WO2008129501A3 (fr) | Compositions pharmaceutiques de duloxetine | |
WO2006097617A3 (fr) | Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux | |
EP1975168A4 (fr) | Derives de pyrazole carboxamides, compositions pharmaceutiques contenant ces composes et fabrication de ceux-ci |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2009521289 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007803868 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12375212 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07803868 Country of ref document: EP Kind code of ref document: A2 |